AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.25, $0.06 better than the analyst estimate of $0.19. Revenue for the quarter came in at $83.9 million versus the consensus estimate of $85.17 million.

GUIDANCE:

AngioDynamics sees FY2018 EPS of $0.70-$0.74, versus the consensus of $0.71. AngioDynamics sees FY2018 revenue of $345-350 million, versus the consensus of $346.58 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.